Dr. Irina TRANDAFIR, PhD in Biology
She is a dedicated and result-oriented Biochemist with a Ph.D. in Biology, from the Doctoral School of Biology at "Alexandru Ioan Cuza" University in Iasi, currently working as a Researcher at TRANSCEND (Center of fundamental research and experimental development in translational medicine) within the Genetics and Molecular Biology Department at the Regional Institute of Oncology (IRO) in Iasi. Throughout her education, she had cultivated general and professional competences in molecular genetics and biology, complemented by a Master's degree in Molecular Genetics and a Bachelor's degree in Biochemistry, both from the Faculty of Biology at "Alexandru Ioan Cuza" University in Iasi. Her professional journey reflects a commitment to advancing knowledge in translational medicine, particularly in the realm of oncology. Her academic experience is characterized by a strong foundation in laboratory practices, including nucleic acid isolation, gene amplification, gene expression quantification and performing more advanced techniques such as Sanger and Next Generation Sequencing. Overall, her professional trajectory reflects a passion for cutting-edge research, collaborative projects, and a commitment to advancing our understanding of molecular biology in the context of oncology.
Since October 2023, she joined the newly formed Nanotechnology Laboratory as postdoctoral researcher within the ESEI-BioMed project. She is part of the group working on development of advanced techniques for cancer detection using RAMAN/SERS spectroscopic analysis of different biological samples. Her role is to perform an in-depth analysis of nucleic acids and other biomolecules extracted from different sources, including biological fluids (such as blood, plasma, etc.), cell lines, and exosomes. Her responsibilities encompass a comprehensive analysis of nucleic acids and other biomolecules derived from diverse samples, by employing specialized protocols for the isolation, purification, and reverse transcription of RNA, as well as DNA analysis. Collaborating with a multidisciplinary team, we aim to integrate findings from nucleic acids analysis and biomolecular investigations into the SERS/MVA approach in order to elucidate molecular signatures associated with cancer in the studied biological samples.